ADIPOQ and hepatocellular carcinoma: Many HCC patients suffer from cirrhosis or fibrosis, both of which are related to the down-regulation of AdipoQ receptors in the liver and the decrease of AdipoQ clearance rate, which leads to AdipoQ resistance state [71].